0001683168-23-002856.txt : 20230502
0001683168-23-002856.hdr.sgml : 20230502
20230502194405
ACCESSION NUMBER: 0001683168-23-002856
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ziebell Mark R
CENTRAL INDEX KEY: 0001552642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 23881197
MAIL ADDRESS:
STREET 1: 14282 FRANKLIN AVENUE
CITY: TUSTIN
STATE: CA
ZIP: 92780
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0407
4
2023-05-01
0
0000704562
Avid Bioservices, Inc.
CDMO
0001552642
Ziebell Mark R
14191 MYFORD ROAD
TUSTIN
CA
92780
0
1
0
0
V. P., General Counsel
1
Common Stock, $0.001 par value
2023-05-01
4
M
0
25000
9.87
A
65119
D
Common Stock, $0.001 par value
2023-05-01
4
S
0
25000
17.9141
D
40119
D
Stock Option (right to buy)
9.87
2023-05-01
4
M
0
25000
0.0000
D
2023-05-06
Common Stock
25000
214145
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2022.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $17.54 to $18.25. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Stock option granted to the reporting person on May 6, 2013 vested in eight (8) equal quarterly installments and was fully-vested as of May 6, 2015.
/s/ Mark R. Ziebell
2023-05-02